Nanobodies

Fuatilia
Scientist in lab examining a mouse with nanobody diagrams in background, illustrating promising research on camelid antibodies for brain disorders.
Picha iliyoundwa na AI

Camelid nanobodies show promise for brain disorders in mice, review says

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

A Cell Press review published on November 5, 2025, highlights tiny camelid-derived antibodies known as nanobodies as potential tools for treating conditions such as Alzheimer’s disease and schizophrenia. The authors say these proteins can reach brain targets in mice more readily than conventional antibodies and outline key steps before human testing.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa